跳至主要内容
临床试验/NCT05024188
NCT05024188Unknown不适用

Assessing the Potential Role of the Gut Microbiome in Modulating Physical Abilities in Humans

Assaf Harofeh MC0 个研究点目标入组 50 人开始时间: 2022年1月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
50
主要终点
Microbiome Profiling

研究概览

简要总结

The intestinal microbiome is a microbial system that is influenced by host genetics and environmental exposures such as nutrition, stress and medications. There is a growing body of evidence indicating the significant contribution of the gut microbiome to host health and disease. Furthermore, it has been shown that exercise may modify the microbiome composition. However, important mechanistic questions related to the possible associations between exercise and the human gut microbiome remain unanswered.

In this study, the investigators are using advanced state-of-the-art measurements of physical activity level and related metabolic parameters whether there is a connection between the microbiome and physical abilities in healthy participants and whether antibiotics consumption can influence host physical abilities and glycemic responses through changes induced in microbiome composition and function.

详细描述

During all days of the study, participants will be connected to a continuous glucose monitor (CGM).

In the second segment of the study, participants will be randomized into two groups: antibiotics or placebo, which will be consumed for 7 days.

The third segment of the trial, participants will undergo an FMT/placebo administration for three consecutive days according to their randomization: participants who received antibiotics will receive FMT and participants who received placebo pills will receive placebo capsules in this segment as well.

During the study, participants will collect stool and buccal samples which will be used for microbiota profiling.

Furthermore, participants will undergo physical abilities test, anthropometric measurements, medical history questioners, blood and urine samples and Dual X-ray absorptiometry (DXA) test.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age - 20-35
  • Are used to exercise in aerobic sports (running, swimming, Zumba, ball games, functional training, surfing, tennis, wrestling ext.).
  • Exercise at least twice a week, for a minimum duration of the last 6 months.

排除标准

  • Consumption of antibiotics (PO) or probiotics 3 months prior to the first day of the experiment.
  • Diagnosis of type 1 or type 2 diabetes.
  • Pregnancy, fertility treatments, breastfeeding women six months prior to enrollment and during the study.
  • Chronic disease (e.g. AIDS, Cushing syndrome, CKD, acromegaly, hyperthyroidism etc.)
  • Cancer and recent anticancer treatment
  • Psychiatric disorders
  • Coagulation disorders
  • Gastrointestinal disorders
  • Bariatric surgery
  • Alcohol or substance abuse
  • Any physical condition precluding the completion of a routine effort test

研究组 & 干预措施

Antibiotics + FMT

Experimental

7 days of antibiotics- Ciprofloxacin, 500 mg 2/day & Metronidazole (Flagyl), 500 mg 3/day. After antibiotics administration, participants will receive 10 aFMT capsules for three consecutive days (a total of 30 capsules).

干预措施: Antibiotics (Drug)

Antibiotics + FMT

Experimental

7 days of antibiotics- Ciprofloxacin, 500 mg 2/day & Metronidazole (Flagyl), 500 mg 3/day. After antibiotics administration, participants will receive 10 aFMT capsules for three consecutive days (a total of 30 capsules).

干预措施: Fecal Microbiota Transplantation (Other)

Placebo

Placebo Comparator

7 days of cellules pills. After cellules pills administration, participants will receive 10 agarose capsules for three consecutive days (a total of 30 capsules).

干预措施: Cellules Pills (Other)

Placebo

Placebo Comparator

7 days of cellules pills. After cellules pills administration, participants will receive 10 agarose capsules for three consecutive days (a total of 30 capsules).

干预措施: Agarose Capsules (Other)

结局指标

主要结局

Microbiome Profiling

时间窗: 2 years

Collection of stool and buccal samples samples for microbiome composition analysis with16s rRNA sequencing.

Body Mass Index (BMI)

时间窗: 2 years

The BMI is defined as the body mass divided by the square of the body height, and is expressed in units of kg/m\^2

Body Circumferences

时间窗: 2 years

waist, hips, and limbs (cm).

次要结局

  • Glycemic Responses(2 years)
  • Bone Mineral Density (BMD)(2 years)

研究者

发起方
Assaf Harofeh MC
申办方类型
Other Gov
责任方
Sponsor Investigator
主要研究者

Assaf Harofeh MC

Principal Investigator

Assaf-Harofeh Medical Center

相似试验